Literature DB >> 165824

The effect of nicotinic acid on the metabolism of the plasma lipoproteins of rhesus monkeys.

A A Magide, N B Myant, D Reichl.   

Abstract

The effect of nicotinic acid was investigated in Rhesus monkeys. Subcutaneous injections of nicotinic acid lower the plasma very low density lipoprotein (VVLDL) and low density lipoprotein (HDL) concentration. The fall in LDL concentration is not accompained by any change in the lipid or protein composition of either lipoprotein. Analysis by Sephadex gel chromatography and polyacrylamide-gel electrophoresis showed that the proteins of monkey VLDL and LDL are qualitatively similar to those of human VLDL and LDL, although there are differences in the proportions of the various proteins present in the two species. Subcutaneous injections of nicotinic acid diminish the maximum incorporation of 14C from [14C]threonine into VLDL and LDL apoproteins, but have no effect on incorporation into albumin or HDL apoprotein. Peak incorporations into the apo-B and apo-C of VLDL are diminished to about equal extents by nicotinic acid. Comparison of the amount of 14C lost from apo-B of VLDL after the peak of incorporation, with that gained by apo-B of LDL during the same period, suggests that some of the circulating apo-B of LDL IS DERIVED FROM SOURCES OTHER THAN CIRCULATING VLDL.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165824     DOI: 10.1016/0021-9150(75)90081-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Nocturnal inhibition of lipolysis in man by nicotinic acid and derivatives.

Authors:  W Kruse; W Kruse; H Raetzer; C C Heuck; P Oster; B Schellenberg; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

2.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

3.  A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.

Authors:  J I Mann; P A Harding; R C Turner; R H Wilkinson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.